Apolipoprotein E (APOE) is closely related to Alzheimer’s disease and other age-related diseases. In recent years, several studies have shown an interaction of APOE by age on brain volume. However, validation in larger cohorts is required.
Objective:
We explored the age-related effect of APOE on brain volumes in a community-dwelling cohort.
Methods:
Inhabitants in Shunyi District in Beijing aged≥35 years were invited to join this study from 2013 to 2016. The baseline assessments, APOE genotyping and brain magnetic resonance imaging were performed. Neuroimaging small vessel disease characteristics and brain volumes (global measures, cerebral lobes, hippocampus, brainstem, and subcortical nuclei) were acquired. The general linear model was used to analyze the interaction of APOE genotypes by age on brain volumes, and the age of 60 years was chosen as a cut-off value for stratification analysis.
Results:
A total of 1,105 subjects were enrolled in the final analysis with a mean age of 56.18 (9.30) years, and 37.7% were men. APOEɛ3/ɛ3 carriers account for 71.8%, ɛ2 (+) 14.0%, and ɛ4 (+) 14.2%. Compared with APOEɛ3/ɛ3, a significant protective effect for APOEɛ4 (+) on brain parenchyma fraction (β = 0.450, p = 0.048) was observed in subjects aged≤60 years; in participants aged > 60 years, a negative effect for APOEɛ4 (+) on hippocampus (β = 1.087, p = 0.021) was found.
Conclusion:
Our study reveals that APOEɛ4 has differential effects on cerebral structures in different stages of lifespan, suggesting its complicated biological function and underlying antagonistic pleiotropy.
PattersonC (2018) World Alzheimer Report 2018. The state of the art of dementia research: New frontiers. Alzheimer’s Disease International, London.
3.
HuynhT-PV, DavisAA, UlrichJD, HoltzmanDM (2017) Apolipoprotein E and Alzheimer’s disease: The influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins. J Lipid Res58, 824–836.
4.
LiZ, ShueF, ZhaoN, ShinoharaM, BuG (2020) APOE2: Protective mechanism and therapeutic implications for Alzheimer’s disease. Mol Neurodegener15, 63.
5.
SaeedU, DesmaraisP, MasellisM (2021) The APOE ɛ4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: A systematic review of magnetic resonance imaging studies and therapeutic relevance. Expert Rev Neurother21, 851–870.
6.
SaeedU, MirzaSS, MacIntoshBJ, HerrmannN, KeithJ, RamirezJ, NestorSM, YuQ, KnightJ, SwardfagerW, PotkinSG, RogaevaE, St George-HyslopP, BlackSE, MasellisM (2018) APOE-ɛ4 associates with hippocampal volume, learning, and memory across spectrum the of Alzheimer’s disease and dementia with Lewy bodies. Alzheimers Dement14, 1137–1147.
7.
GorbachT, PudasS, Bartrés-FazD, BrandmaierAM, DüzelS, HensonRN, IdlandA-V, LindenbergerU, MaciàBros D, MowinckelAM, Solé-PadullésC, SørensenØ, WalhovdKB, WatneLO, WesterhausenR, FjellAM, NybergL (2020) Longitudinal association between hippocampus atrophy and episodic-memory decline in non-demented APOE ɛ4 carriers. Alzheimers Dement (Amst)12, e12110.
8.
ArdekaniBA, IzadiNO, HadidSA, MeftahAM, BachmanAH (2020) Effects of sex, age, and apolipoprotein E genotype on hippocampal parenchymal fraction in cognitively normal older adults. Psychiatry Res Neuroimaging301, 111107.
9.
HallerS, MontandonM-L, RodriguezC, GaribottoV, HerrmannFR, GiannakopoulosP (2019) Hippocampal volume loss, brain amyloid accumulation, and APOE status in cognitively intact elderly subjects. Neurodegener Dis19, 139–147.
10.
ReasET, LaughlinGA, BergstromJ, Kritz-SilversteinD, Barrett-ConnorE, McEvoyLK (2019) Effects of APOE on cognitive aging in community-dwelling older adults. Neuropsychology33, 406–416.
11.
IaconoD, FeltisGC (2019) Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan. Aging11, 787–816.
12.
TuminelloER, HanSD (2011) The apolipoprotein e antagonistic pleiotropy hypothesis: Review and recommendations. Int J Alzheimers Dis2011, 726197.
13.
MuellerSG, SchuffN, RaptentsetsangS, ElmanJ, WeinerMW (2008) Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer’s disease using high resolution MRI at 4 T. Neuroimage42, 42–48.
14.
ChenJ, ShuH, WangZ, LiuD, ShiY, ZhangX, ZhangZ (2015) The interaction of APOE genotype by age in amnestic mild cognitive impairment: A voxel-based morphometric study. J Alzheimers Dis43, 657–668.
15.
CacciagliaR, MolinuevoJL, FalcónC, Brugulat-SerratA, Sánchez-BenavidesG, GramuntN, EstellerM, MoránS, MinguillónC, FauriaK, GispertJD, ALFA study
(2018) Effects of APOE-ɛ4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease. Alzheimers Dement14, 902–912.
16.
Martí-JuanG, Sanroma-GuellG, CacciagliaR, FalconC, OpertoG, MolinuevoJL, González BallesterMÁ, GispertJD, PiellaG, Alzheimer’s Disease Neuroimaging Initiative, ALFA Study
(2021) Nonlinear interaction between APOE ɛ4 allele load and age in the hippocampal surface of cognitively intact individuals. Hum Brain Mapp42, 47–64.
17.
Serrano-PozoA, DasS, HymanBT (2021) APOE and Alzheimer’s disease: Advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol20, 68–80.
18.
SuN, ZhaiF-F, ZhouL-X, NiJ, YaoM, LiM-L, JinZ-Y, GongG-L, ZhangS-Y, CuiL-Y, TianF, ZhuY-C (2017) Cerebral small vessel disease burden is associated with motor performance of lower and upper extremities in community-dwelling populations. Front Aging Neurosci9, 313.
19.
GreenbergSM, VernooijMW, CordonnierC, ViswanathanA, Al-Shahi SalmanR, WarachS, LaunerLJ, Van BuchemMA, BretelerMM, Microbleed Study Group (2009) Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol8, 165–174.
20.
ZhuY-C, TzourioC, SoumaréA, MazoyerB, DufouilC, ChabriatH (2010) Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: A population-based study. Stroke41, 2483–2490.
21.
SuN, LiangX, ZhaiF, ZhouL, NiJ, YaoM, TianF, ZhangS, JinZ, CuiL, GongG, ZhuY (2018) The consequence of cerebral small vessel disease: Linking brain atrophy to motor impairment in the elderly. Hum Brain Mapp39, 4452–4461.
22.
PatenaudeB, SmithSM, KennedyDN, JenkinsonM (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage56, 907–922.
23.
HuebbeP, RimbachG (2017) Evolution of human apolipoprotein E (APOE) isoforms: Gene structure, protein function and interaction with dietary factors. Ageing Res Rev37, 146–161.
24.
MalykhinNV, TravisS, FujiwaraE, HuangY, CamicioliR, OlsenF (2020) The associations of the BDNF and APOE polymorphisms, hippocampal subfield volumes, and episodic memory performance across the lifespan. Hippocampus30, 1081–1097.
25.
MuellerSG, WeinerMW (2009) Selective effect of age, Apo e4, and Alzheimer’s disease on hippocampal subfields. Hippocampus19, 558–564.
26.
KhanS, BarveKH, KumarMS (2020) Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease. Curr Neuropharmacol18, 1106–1125.
27.
MitteldorfJ (2019) What is antagonistic pleiotropy?Biochem Biokhimiia84, 1458–1468.
28.
SonntagWE, LynchCD, CefaluWT, IngramRL, BennettSA, ThorntonPL, KhanAS (1999) Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: Inferences from moderate caloric-restricted animals. J Gerontol A Biol Sci Med Sci54, B521–538.
29.
SalminenA, KaarnirantaK, KauppinenA (2021) Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: Impact on the aging process and age-related diseases. Inflamm Res70, 1043–1061.
30.
FranceschiC, GaragnaniP, PariniP, GiulianiC, SantoroA (2018) Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol14, 576–590.
31.
ByarsSG, VoskaridesK (2020) Antagonistic pleiotropy in human disease. J Mol Evol88, 12–25.
32.
GaynorJW, KimDS, ArringtonCB, AtzAM, BellingerDC, BurtAA, GhanayemNS, JacobsJP, LeeTM, LewisAB, MahleWT, MarinoBS, MillerSG, NewburgerJW, PizarroC, RavishankarC, SantaniAB, WilderNS, JarvikGP, MitalS, RussellMW (2014) Validation of association of the apolipoprotein E ɛ2 allele with neurodevelopmental dysfunction after cardiac surgery in neonates and infants. J Thorac Cardiovasc Surg148, 2560–2566.
33.
BlossCS, DelisDC, SalmonDP, BondiMW (2010) APOE genotype is associated with left-handedness and visuospatial skills in children. Neurobiol Aging31, 787–795.
34.
SteningE, PerssonJ, ErikssonE, WahlundL-O, ZetterbergH, SöderlundH (2016) Apolipoprotein E ε4 is positively related to spatial performance but unrelated to hippocampal volume in healthy young adults. Behav Brain Res299, 11–18.
35.
vanExel E, KoopmanJJE, BodegomD van, MeijJJ, KnijffP de, ZiemJB, FinchCE, WestendorpRGJ (2017) Effect of APOE ɛ4 allele on survival and fertility in an adverse environment, PloS One12, e0179497.
36.
SchellerE, PeterJ, SchumacherLV, LahrJ, MaderI, KallerCP, KlöppelS (2017) APOE moderates compensatory recruitment of neuronal resources during working memory processing in healthy older adults. Neurobiol Aging56, 127–137.
